BIOMAT Database Logo BIOMAT Database Logo

[Anti-arrhythmia agents: classification, mechanisms of action, principles of drug choice in clinical practice]. 1993

A S Smetnev, and N M Shevchenko, and A A Grosu

UI MeSH Term Description Entries
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000889 Anti-Arrhythmia Agents Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. Anti-Arrhythmia Agent,Anti-Arrhythmia Drug,Anti-Arrhythmic,Antiarrhythmia Agent,Antiarrhythmia Drug,Antiarrhythmic Drug,Antifibrillatory Agent,Antifibrillatory Agents,Cardiac Depressant,Cardiac Depressants,Myocardial Depressant,Myocardial Depressants,Anti-Arrhythmia Drugs,Anti-Arrhythmics,Antiarrhythmia Agents,Antiarrhythmia Drugs,Antiarrhythmic Drugs,Agent, Anti-Arrhythmia,Agent, Antiarrhythmia,Agent, Antifibrillatory,Agents, Anti-Arrhythmia,Agents, Antiarrhythmia,Agents, Antifibrillatory,Anti Arrhythmia Agent,Anti Arrhythmia Agents,Anti Arrhythmia Drug,Anti Arrhythmia Drugs,Anti Arrhythmic,Anti Arrhythmics,Depressant, Cardiac,Depressant, Myocardial,Depressants, Cardiac,Depressants, Myocardial,Drug, Anti-Arrhythmia,Drug, Antiarrhythmia,Drug, Antiarrhythmic,Drugs, Anti-Arrhythmia,Drugs, Antiarrhythmia,Drugs, Antiarrhythmic
D001145 Arrhythmias, Cardiac Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction. Arrhythmia,Arrythmia,Cardiac Arrhythmia,Cardiac Arrhythmias,Cardiac Dysrhythmia,Arrhythmia, Cardiac,Dysrhythmia, Cardiac
D015716 Electrocardiography, Ambulatory Method in which prolonged electrocardiographic recordings are made on a portable tape recorder (Holter-type system) or solid-state device ("real-time" system), while the patient undergoes normal daily activities. It is useful in the diagnosis and management of intermittent cardiac arrhythmias and transient myocardial ischemia. Ambulatory Electrocardiography,Electrocardiography, Dynamic,Electrocardiography, Holter,Holter ECG,Holter EKG,Holter Monitoring,Monitoring, Ambulatory Electrocardiographic,Monitoring, Holter,Ambulatory Electrocardiography Monitoring,Dynamic Electrocardiography,Electrocardiography Monitoring, Ambulatory,Holter Electrocardiography,Ambulatory Electrocardiographic Monitoring,ECG, Holter,ECGs, Holter,EKG, Holter,EKGs, Holter,Electrocardiographic Monitoring, Ambulatory,Holter ECGs,Holter EKGs,Monitoring, Ambulatory Electrocardiography

Related Publications

A S Smetnev, and N M Shevchenko, and A A Grosu
[Mechanisms of cellular action of anti-arrhythmia agents].
January 1978, Coeur et medecine interne,
A S Smetnev, and N M Shevchenko, and A A Grosu
[Principles for the classification of anti-arrhythmia agents in cardiac arrhythmias].
January 1992, Zeitschrift fur Kardiologie,
A S Smetnev, and N M Shevchenko, and A A Grosu
[Mechanisms of action of class III anti-arrhythmia agents].
January 1995, Archives des maladies du coeur et des vaisseaux,
A S Smetnev, and N M Shevchenko, and A A Grosu
[Cellular mechanisms of the action of anti-arrhythmia agents].
January 1978, Kardiologia polska,
A S Smetnev, and N M Shevchenko, and A A Grosu
[Classification of anti-arrhythmia drugs and their mechanism of action. Iatrogeny of anti-arrhythmia agents].
April 1992, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology,
A S Smetnev, and N M Shevchenko, and A A Grosu
[Anti-arrhythmia agents: classification, mode of action, and therapeutic usefulness].
March 1993, Revista clinica espanola,
A S Smetnev, and N M Shevchenko, and A A Grosu
[Choice of anti-arrhythmia agents: the arrhythmia-patient binomial].
April 1992, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology,
A S Smetnev, and N M Shevchenko, and A A Grosu
[Present classification of anti-arrhythmia agents].
November 1985, Nihon rinsho. Japanese journal of clinical medicine,
A S Smetnev, and N M Shevchenko, and A A Grosu
[Current classification of anti-arrhythmia agents].
January 2000, Zeitschrift fur Kardiologie,
A S Smetnev, and N M Shevchenko, and A A Grosu
[Combined action of anti-arrhythmia agents].
June 1991, Biulleten' eksperimental'noi biologii i meditsiny,
Copied contents to your clipboard!